Tel: 021-33665188 · Fax: 021-33665180 · Email: infochina@grs-cro.com

Global Research Services (GRS) is pleased to present our full clinical trial management services for the vaccine community under its new division, Global Vaccine Services. In conjunction with the nationwide Passport Health clinics located across the United States, and our relationship with Parkway Holdings and Gleneagles CRC, the largest hospital management team in Asia, we are uniquely positioned to recruit patients for large-scale vaccine clinical trials around the world.
In addition to trained investigator sites and access to significant pool of qualified patients, Global Vaccine Services provides consultative services in:
We’ve combined our large clinical trial management experience (Phase I-IV) and paired it with specialized vaccine distribution sites, a clinical trial educational initiative and vaccine development consultants to produce a powerful clinical vaccine development service.
You will benefit from our unique strategic relationships in the U.S. through Passport Health (The Vaccine People™) supporting over 150 clinics, the single largest purchaser of vaccines in the U.S. as well as the single private provider of the Anthrax vaccine. We’ve also extended our reach into Asia with our affiliations in China through Parkway Holdings and Gleneagles CRC, the largest hospital management team in Asia. We have also trained our participating sites through an innovative and interactive Web-based Clinical Trails Management course created by GRS and the University of Rochester Medical School, thus producing the largest cohort of trained sites for vaccines research organized and integrated under a CRO umbrella.
Our strategic relationship with an outstanding academic healthcare institution has distinctively positioned us in the world of vaccines development:
Strategic relationships with industry vaccine experts: